PRESS RELEASE published on 06/01/2023 at 22:05, 3 years 2 months ago Moderna to Present at Upcoming Conferences in June 2023
PRESS RELEASE published on 05/30/2023 at 14:00, 3 years 2 months ago Moderna Announces Phase 2 Data on mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, to be Presented at the 2023 ASCO Annual Meeting
PRESS RELEASE published on 05/19/2023 at 13:00, 3 years 2 months ago Phase 1/2 Interim Data on Moderna's mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA), Presented at the 2023 ASGCT Annual Meeting
PRESS RELEASE published on 05/04/2023 at 12:30, 3 years 3 months ago Moderna Reports First Quarter 2023 Financial Results and Provides Business Updates
PRESS RELEASE published on 05/03/2023 at 22:05, 3 years 3 months ago Moderna Announces Phase 1/2 Data on mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA) to be Presented at the 2023 ASGCT Annual Meeting
PRESS RELEASE published on 05/02/2023 at 23:15, 3 years 3 months ago Moderna Announces Establishment of an Enterprise Solutions Hub and Commercial Operations in The Philippines
PRESS RELEASE published on 04/20/2023 at 22:05, 3 years 3 months ago Moderna to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023
PRESS RELEASE published on 04/20/2023 at 13:30, 3 years 3 months ago Moderna and IBM to Explore Quantum Computing and Generative AI for mRNA Science
PRESS RELEASE published on 04/16/2023 at 17:00, 3 years 3 months ago Moderna and Merck Announce mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, in Combination with KEYTRUDA(R) (Pembrolizumab), Demonstrated Superior Recurrence-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following C
PRESS RELEASE published on 04/11/2023 at 13:00, 3 years 4 months ago Moderna Announces Clinical and Program Updates at 4th Vaccines Day
Published on 08/13/2026 at 09:05, 2 hours 6 minutes ago Battery X Metals Appoints Lithium-Ion Battery and Electric Vehicle Entrepreneur William Fan as President to Advance Development of Its Patent-Pending Lithium-Ion Battery Rebalancing Technology Platform and Corporate Growth Initiatives
Published on 08/13/2026 at 08:00, 3 hours 11 minutes ago Battery X Metals Maintains Y Lithium Project Claims in Good Standing and Evaluates Phase I Exploration Program
Published on 08/13/2026 at 07:30, 3 hours 41 minutes ago Battery X Metals Announces Closing of Second Tranche of Private Placement to Advance Corporate Growth Initiatives
Published on 08/13/2026 at 00:30, 10 hours 41 minutes ago Aton Closes CAD$4 Million Private Placement
Published on 08/12/2026 at 23:30, 11 hours 41 minutes ago CCL Industries Announces Record Results for 2026 Second Quarter
Published on 08/13/2026 at 11:05, 6 minutes ago BIRKENSTOCK REPORTS FISCAL THIRD QUARTER 2026 RESULTS WITH 15% CONSTANT F/X REVENUE GROWTH LED BY DTC; RAISES GUIDANCE FOR FY26
Published on 08/13/2026 at 11:00, 11 minutes ago ABB Ltd: ABB share buybacks - August 6, 2026 - August 12, 2026
Published on 08/13/2026 at 10:13, 57 minutes ago Turkiye Garanti Bankasi A.S.: Issuance of Green/Sustainable Eurobond
Published on 08/13/2026 at 10:09, 1 hour 1 minute ago Turkiye Garanti Bankasi A.S.: Redemption of the debt instrument at abroad within the Medium Term Note (MTN) program
Published on 08/11/2026 at 17:45, 1 day 17 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 17 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 17 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 17 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
